auranofin , an oral chrysotherapeutic agent effective in the treatment of rheumatoid arthritis ( ra ) , was found to be a potent , noncytotoxic inhibitor of igg-rf immune complex-induced lysosomal enzyme release ( ler ) from human leukocytes .
C0004320
auranofin
C0003873
rheumatoid arthritis